Lack of effect of murine norovirus infection on a mouse model of bacteria-induced colon cancer

Comparative Medicine

Volumn 61, Issue 3, 2011, Pages 219-226

  Lencioni, Karen C ^a,b   Drivdahl, Rolf ^a   Seamons, Audrey ^a   Treuting, Piper M ^a   Brabb, Thea ^a   Maggio Price, Lillian ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; SMAD3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; SMAD3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CALICIVIRUS INFECTION; CELL CULTURE; COLON CANCER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; ENTERITIS; FEMALE; GENETIC SUSCEPTIBILITY; HELICOBACTER INFECTION; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MALE; MOUSE; MURINE NOROVIRUS INFECTION; NONHUMAN; NOROVIRUS; PHENOTYPE; ANIMAL; ANIMAL DISEASE; COLON TUMOR; DISEASE MODEL; GENETICS; HELICOBACTER; IMMUNOLOGY; INCIDENCE; INFLAMMATION; METABOLISM; MICROBIOLOGY; PATHOLOGY; RODENT DISEASE; SURVIVAL; VIROLOGY;

ANIMALS; CALICIVIRIDAE INFECTIONS; COLONIC NEOPLASMS; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HELICOBACTER; HELICOBACTER INFECTIONS; INCIDENCE; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; MACROPHAGES; MICE; NOROVIRUS; PHENOTYPE; RODENT DISEASES; SMAD3 PROTEIN; SURVIVAL ANALYSIS;

EID: 84856001407     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Baker DG. 1998. Natural pathogens of laboratory mice, rats, and rabbits and their effects on research. Clin Microbiol Rev 11:231-266. (Pubitemid 28197353)
2. Boivin GP, Washington K, Yang K, Ward JM, Pretlow TP, Russell R, Besselsen DG, Godfrey VL, Doetschman T, Dove WF, Pitot HC, Halberg RB, Itzkowitz SH, Groden J, Coffey RJ. 2003. Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology 124:762-777. (Pubitemid 36268493)
3. Burich A, Hershberg R, Waggie K, Zeng W, Brabb T, Westrich G, Viney JL, Maggio-Price L. 2001. Helicobacter-induced inflammatory bowel disease in IL10- and T-cell-deficient mice. Am J Physiol Gastrointest Liver Physiol 281:G764-G778.
4. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159. (Pubitemid 17064313)
5. Daughenbaugh KF, Wobus CE, Hardy ME. 2006. VPg of murine norovirus binds translation initiation factors in infected cells. Virol J 3:33.
6. Doom CM, Turula HM, Hill AB. 2009. Investigation of the impact of the common animal facility contaminant murine norovirus on experimental murine cytomegalovirus infection. Virology 392:153-161.
7. Englen MD, Valdez YE, Lehnert NM, Lehnert BE. 1995. Granulocyte- macrophage colony-stimulating factor is expressed and secreted in cultures of murine L929 cells. J Immunol Methods 184:281-283.
8. Hartley JW, Evans LH, Green KY, Naghashfar Z, Macias AR, Zerfas PM, Ward JM. 2008. Expression of infectious murine leukemia viruses by RAW264.7 cells, a potential complication for studies with a widely used mouse macrophage cell line. Retrovirology 5:1.
9. Henderson KS. 2008. Murine norovirus, a recently discovered and highly prevalent viral agent of mice. Lab Anim (NY) 37:314-320. (Pubitemid 351873459)
10. Hensley SE, Pinto AK, Hickman HD, Kastenmayer RJ, Bennink JR, Virgin HW, Yewdell JW. 2009. Murine norovirus infection has no significant effect on adaptive immunity to vaccinia virus or influenza A virus. J Virol 83:7357-7360.
11. Hsu CC, Riley LK, Wills HM, Livingston RS. 2006. Persistent infection with and serologic cross-reactivity of 3 novel murine noroviruses. Comp Med 56:247-251. (Pubitemid 44299965)
12. Hsu CC, Wobus CE, Steffen EK, Riley LK, Livingston RS. 2005. Development of a microsphere-based serologic multiplexed fluorescent immunoassay and a reverse-transcriptase-PCR assay to detect murine norovirus 1 infection in mice. Clin Diagn Lab Immunol 12:1145-1151. (Pubitemid 41475821)
13. Karst SM, Wobus CE, Lay M, Davidson J, Virgin HW 4th. 2003. STAT1-dependent innate immunity to a Norwalk-like virus. Science 299: 1575-1578. (Pubitemid 36297707)
14. Kelmenson JA, Pomerleau DP, Griffey S, Zhang W, Karolak MJ, Fahey JR. 2009. Kinetics of transmission, infectivity, and genome stability of 2 novel mouse norovirus isolates in breeding mice. Comp Med 59:27-36.
15. Kim M, Lee H, Chang KO, Ko G. 2010. Molecular characterization of murine norovirus isolates from South Korea. Virus Res 147:1-6.
16. Ko G, Jiang ZD, Okhuysen PC, DuPont HL. 2006. Fecal cytokines and markers of intestinal inflammation in international travelers with diarrhea due to noroviruses. J Med Virol 78:825-828.
17. Lencioni KC, Seamons A, Treuting PM, Maggio-Price L, Brabb T. 2008. Murine norovirus: an intercurrent variable in a mouse model of bacteria-induced inflammatory bowel disease. Comp Med 58:522-533.
18. Lindsey JR, Boorman GA, Collins MJ, Hsu C, Van Hoosier GL, Wagner JE. 1991. Infectious diseases of mice and rats. Washington (DC): National Academies Press.
19. Liu G, Kahan SM, Jia Y, Karst SM. 2009. Primary high-dose murine norovirus 1 infection fails to protect from secondary challenge with homologous virus. J Virol 83:6963-6968.
20. Maggio-Price L, Shows D, Waggie K, Burich A, Zeng W, Escobar S, Morrissey P, Viney JL. 2002. Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a-/-) mice. Am J Pathol 160:739-751. (Pubitemid 34160352)
21. Maggio-Price L, Treuting P, Bielefeldt-Ohmann H, Seamons A, Drivdahl R, Zeng W, Lai L, Huycke M, Phelps S, Brabb T, Iritani BM. 2009. Bacterial infection of Smad3-Rag2 double-null mice with transforming growth factor-β dysregulation as a model for studying inflammation-associated colon cancer. Am J Pathol 174:317-329.
22. Maggio-Price L, Treuting P, Zeng W, Tsang M, Bielefeldt-Ohmann H, Iritani BM. 2006. Helicobacter infection is required for inflammation and colon cancer in SMAD3-deficient mice. Cancer Res 66:828-838. (Pubitemid 43165948)
23. McCartney SA, Thackray LB, Gitlin L, Gilfillan S, Virgin HW, Colonna M. 2008. MDA5 recognition of a murine norovirus. PLoS Pathog 4:e1000108.
24. Muller B, Klemm U, Mas Marques A, Schreier E. 2007. Genetic diversity and recombination of murine noroviruses in immunocompromised mice. Arch Virol 152:1709-1719. (Pubitemid 47319269)
25. Mumphrey SM, Changotra H, Moore TN, Heimann-Nichols ER, Wobus CE, Reilly MJ, Moghadamfalahi M, Shukla D, Karst SM. 2007. Murine norovirus 1 infection is associated with histopathological changes in immunocompetent hosts, but clinical disease is prevented by STAT1-dependent interferon responses. J Virol 81:3251-3263. (Pubitemid 46456634)
26. Paik J, Fierce Y, Drivdahl R, Treuting PM, Seamons A, Brabb T, Maggio-Price L. 2010. Effects of murine norovirus infection on a mouse model of diet-induced obesity and insulin resistance. Comp Med 60:189-195.
27. Perdue KA, Green KY, Copeland M, Barron E, Mandel M, Faucette LJ, Williams EM, Sosnovtsev SV, Elkins WR, Ward JM. 2007. Naturally occurring murine norovirus infection in a large research institution. J Am Assoc Lab Anim Sci 46:39-45. (Pubitemid 351182141)
28. Solinas G, Germano G, Mantovani A, Allavena P. 2009. Tumorassociated macrophages (TAM) as major players of the cancer-related inflammation. J Leukoc Biol 86:1065-1073.
29. Ward JM, Wobus CE, Thackray LB, Erexson CR, Faucette LJ, Belliot G, Barron EL, Sosnovtsev SV, Green KY. 2006. Pathology of immunodeficient mice with naturally occurring murine norovirus infection. Toxicol Pathol 34:708-715. (Pubitemid 44665523)
30. Wobus CE, Karst SM, Thackray LB, Chang KO, Sosnovtsev SV, Belliot G, Krug A, Mackenzie JM, Green KY, Virgin HW. 2004. Replication of norovirus in cell culture reveals a tropism for dendritic cells and macrophages. PLoS Biol 2:e432.
31. Wobus CE, Thackray LB, Virgin HW 4th. 2006. Murine norovirus: a model system to study norovirus biology and pathogenesis. J Virol 80:5104-5112.
32. Yeom SC, Yu SA, Choi EY, Lee BC, Lee WJ. 2009. Prevalence of Helicobacter hepaticus, murine norovirus, and Pneumocystis carinii and eradication efficacy of cross-fostering in genetically engineered mice. Exp Anim 58:497-504.